[Federal Register Volume 63, Number 125 (Tuesday, June 30, 1998)]
[Proposed Rules]
[Page 35551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17293]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 16 and 99


Single Issue Focus Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's Office of Consumer Affairs 
is announcing a Single Issue Focus Meeting. The meeting will provide an 
opportunity for consumers, patient advocates, health professionals, and 
industry to learn about and comment on the proposed rule published in 
the Federal Register of June 8, 1998, on section 401 of the Food and 
Drug Administration Modernization Act of 1997 and the dissemination of 
information on unapproved/new uses for marketed drugs, biologics, and 
devices.
Dates: The meeting will be held on Wednesday, July 8, 1998, from 1:30 
p.m. to 4:30 p.m. Send information regarding registration by July 6, 
1998.
ADDRESSES: The meeting will be held at the Wilbur J. Cohen Bldg., Snow 
Room, 330 Independence Ave., SW., Washington, DC. Metro Stop: Blue or 
Orange Line to Federal Center, SW.
FOR FURTHER INFORMATION CONTACT: Michael D. Anderson, Office of 
Consumer Affairs (HFE-40), Food and Drug Administration, Parklawn 
Bldg., 5600 Fishers Lane, Rockville, MD 20857, 301-827-4417, FAX 301-
443-9767, E-mail: SMTP[M[email protected]].
SUPPLEMENTARY INFORMATION: Send registration information (including 
name, title, organization, address, telephone, fax number, and any 
requests for oral presentations) to the contact person (address above) 
by July 6, 1998. Any requests for oral presentations should include a 
brief summary of the presentation and the approximate amount of time 
requested for the presentation. The agency requests that persons or 
groups having similar interests consolidate their presentations and 
present them through a single representative. Every effort will be made 
to accommodate all registrants and requests for oral presentations. 
However because space and time is limited, admittance is on a ``first 
come, first serve basis,'' and the agency may not be able to 
accommodate all requests for oral presentations.
    If you need special accommodations due to a disability, please 
contact Michael D. Anderson (address above) by July 6, 1998.
    Transcripts of the meeting may be requested in writing from the 
Freedom of Information Office (HFI-35), Food and Drug Administration, 
5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, approximately 15 
working days after the meeting at a cost of 10 cents per page.

    Dated: June 23, 1998.
William B. Schultz,
Deputy Commissioner for Policy.
[FR Doc. 98-17293 Filed 6-29-98; 8:45 am]
BILLING CODE 4160-01-F